Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 11/20 | 0.47 |
| ▸ | TACR2 | P21452 | 1/20 | 0.39 |
| ▸ | FDPS | P14324 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.37 |
| ▸ | HPGD | P15428 | 3/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 3/20 | 0.35 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.33 |
| ▸ | MAOA | P21397 | 1/20 | 0.33 |
| ▸ | MAOB | P27338 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL360286 | 0.79 | ALDH1A1 (0.47) | ALDH1A1FDPSHPGDTDP1MAPT | |
| SCHEMBL27407171 | 0.74 | FDPS (0.33) | ALDH1A1FDPSSMN1; SMN2 | |
| SCHEMBL11513183 | 0.73 | NQO1 (0.36) | ALDH1A1L3MBTL1HPGDTDP1MAPT | |
| SCHEMBL128388 | 0.73 | NQO1 (0.46) | ALDH1A1HPGDTDP1MAPTKDM4E | |
| SCHEMBL160927 | 0.72 | NQO1 (0.34) | L3MBTL1TDP1 | |
| SCHEMBL3048684 | 0.72 | LTA4H (0.38) | ALDH1A1HPGDMAPTKDM4ETSHR | |
| SCHEMBL15352630 | 0.72 | NQO1 (0.34) | — | |
| SCHEMBL7690729 | 0.72 | NQO1 (0.34) | — | |
| SCHEMBL6602231 | 0.72 | TP53 (0.46) | ALDH1A1L3MBTL1HPGDTDP1MAPT | |
| SCHEMBL157423 | 0.72 | TSHR (0.37) | ALDH1A1L3MBTL1HPGDTDP1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210214644-A1 | PERFUME PRECURSOR | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2021-07-15 | — | — | US | claimed |
| EP-3689849-A1 | PERFUME PRECURSOR | Takasago International Corporation (JP) | 2020-08-05 | — | — | EP | claimed |
| EP-2652102-B1 | MOC COMPOSITIONS | GIVAUDAN SA (CH) | 2016-09-14 | — | — | EP | claimed |
| US-9125828-B2 | MOC compositions | GIVAUDAN SA (CH) | 2015-09-08 | — | — | US | claimed |
| US-20130336911-A1 | MOC Compositions | GIVAUDAN SA (CH) | 2013-12-19 | — | — | US | claimed |
| EP-2652102-A1 | MOC COMPOSITIONS | Givaudan SA (CH) | 2013-10-23 | — | — | EP | claimed |
| WO-2012080235-A1 | MOC COMPOSITIONS | GIVAUDAN SA (CH) | 2012-06-21 | — | — | WO | claimed |
| US-11802258-B2 | Perfume precursor | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2023-10-31 | — | — | US | disclosed |
| US-20210214644-A1 | PERFUME PRECURSOR | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2021-07-15 | — | — | US | disclosed |
| EP-3689849-A1 | PERFUME PRECURSOR | Takasago International Corporation (JP) | 2020-08-05 | — | — | EP | disclosed |
| EP-2652102-B1 | MOC COMPOSITIONS | GIVAUDAN SA (CH) | 2016-09-14 | — | — | EP | disclosed |
| US-9125828-B2 | MOC compositions | GIVAUDAN SA (CH) | 2015-09-08 | — | — | US | disclosed |
| US-9125828-B2 | MOC compositions | GIVAUDAN SA (CH) | 2015-09-08 | — | — | US | disclosed |
| WO-2012080235-A1 | MOC COMPOSITIONS | GIVAUDAN SA (CH) | 2012-06-21 | — | — | WO | disclosed |
| US-7855194-B2 | Pyrimidine, quinazoline, pteridine and triazine derivatives | HOFFMANN-LA ROCHE INC. (US) | 2010-12-21 | — | — | US | disclosed |
| US-20090047223-A1 | Improvements in or Related to Organic Compoounds | GIVAUDAN SA (CH) | 2009-02-19 | — | — | US | disclosed |
| EP-1966117-A1 | IMPROVEMENTS IN OR RELATED TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2008-09-10 | — | — | EP | disclosed |
| US-20070225271-A1 | Pyrimidine, quinazoline, pteridine and triazine derivatives | F. HOFFMANN-LA ROCHE AG, A SWISS COMPANY (CH) | 2007-09-27 | — | — | US | disclosed |
| WO-2007071085-A1 | IMPROVEMENTS IN OR RELATED TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2007-06-28 | — | — | WO | disclosed |
| US-6306818-B1 | ESTER, THIOESTER, ORGANIC CARBONATE AND/OR THIOCARBONATE DERIVATIVES; COSMETICS, DETERGENTS, FABRIC SOFTENERS, ANTIPERSPIRANTS; SUSTAINED SCENT | GIVAUDAN ROURE (INTERNATIONAL) SA (CH) | 2001-10-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11802258-B2 | Perfume precursor | CYP2E1, ADH1A, CYP1A1 | ALDH1A1 26/4885TACR2 2823/4885FDPS 555/4885 |
| US-20070225271-A1 | Pyrimidine, quinazoline, pteridine and triazine derivatives | SSTR5, SSTR3, SSTR1 | ALDH1A1 2891/4885TACR2 55/4885FDPS 1437/4885 |
| US-20210214644-A1 | PERFUME PRECURSOR | CYP2E1, ADH1A, CYP1A1 | ALDH1A1 26/4885TACR2 2823/4885FDPS 555/4885 |
| US-20090047223-A1 | Improvements in or Related to Organic Compoounds | LPO, OTC, OAT | ALDH1A1 296/4885TACR2 3667/4885FDPS 12/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.